With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened this year. And there are many! The accomplishments, opportunities and possibilities the scientific community has brought to bear, providing a way out of the COVID-19 pandemic and hope for the future of […]

The US Food and Drug Administration (FDA) has granted 510(k) clearance for the fully automated SeptiCyte RAPID test from Immunexpress. Developed in collaboration with Biocartis Group, the test distinguishes sepsis from non-infectious systemic inflammation in patients who are suspected of having sepsis.

In an interview with PharmaShots, Dr. Murat Kalayoglu, MD, Ph.D., President, and Chief Executive Officer at Cartesian Therapeutics shared his insights on the P-I/IIa study of Descartes-08 for the treatment of the chronic autoimmune disorder generalized myasthenia gravis (gMG) Shots: Descartes-08 is an autologous T-cell product that is engineered with RNA to encode for CAR The company focuses to use […]